Lupus Nephritis: New Treatments to Improve Patient Outcomes
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Vindico Medical Education
Events
Register today for upcoming in-person and virtual events.
IBD NOW Summit for Advanced Practice Providers
This activity is supported by educational grants from AbbVie Inc.; Genentech, a member of the Roche Group; Johnson & Johnson; Lilly; and Merck & Co., Inc.
Vindico at IDCNY 2026
These activities are held during IDCNY 2026
Online Activities
Learn and earn credit any time, at your own pace.
The Retina Radar Season 4 With Dr. Arshad Khanani: Clinical Trials at the Summit 2026 With Drs. David Boyer and Anat Loewenstein
This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
The Retina Radar Season 4 With Dr. Arshad Khanani: Latest in nAMD Management in 2026 With Dr. Yasha Modi
This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
The Retina Radar Season 4 With Dr. Arshad Khanani: Latest in DME Management in 2026 With Dr. Margaret Chang
This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
The Retina Radar Season 4 With Dr. Arshad Khanani: What’s New for RVO in 2026? With Dr. Ehsan Rahimy
This activity is supported by independent educational grants from 4D Molecular Therapeutics; AbbVie Inc.; Alkeus Pharmaceuticals, Inc.; ANI Pharmaceuticals, Inc.; EyePoint; Genentech, a member of the Roche Group; Merck & Co., Inc.; Neurotech Pharmaceuticals, Inc.; Ocular Therapeutix, Inc.; Ollin Biosciences, Inc.; Opus Genetics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
Tools & Resources
View or download to use in your daily practice.
